MedPath

Nutritional Supplement for Treating Chemotherapy Induced Neuropathy

Phase 4
Completed
Conditions
Cancer
Neuropathy
Chemotherapy Induced Pain Neuropathy
Chemotherapy-Induced Peripheral Neuropathy
Registration Number
NCT07022938
Lead Sponsor
Aristotle University Of Thessaloniki
Brief Summary

Administration of a nutritional supplement containing palmitoyethanolamide, alpha lipoic acid, vitamin B12, vitamin B6 , vitamin B1, nicotinamide, magnesium, zinc, vitamin E, and superoxide of dismutase in individuals receiving chemotherapy

Detailed Description

Investigation of effectiveness and safety of a nutritional supplement containing palmitoyethanolamide, alpha lipoic acid, vitamin B12, vitamin B6 , vitamin B1, nicotinamide, magnesium, zinc, vitamin E, and superoxide of dismutase in individuals receiving chemotherapy

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
71
Inclusion Criteria
  • Newly diagnosed patients with cancer that have not received yet their treatment
  • Patients that will be treated with platinum agents or taxanes
Exclusion Criteria
  • Not receiving dietary supplement

  • Have already neuropathy

  • Have already started chemotherapy

  • Patients with uncontrolled diabetes

    -- Patients with chronic kidney disease

  • Patiens with recent cardiovascular incident

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Neuropathic Pain Symptom Inventory6 months

scale for neuropathic pain symptoms

PAIN Detect score6 months

score for neuropathic pain

Secondary Outcome Measures
NameTimeMethod
Visual Analogue scale6 months

scale for pain

Nerve conduction velocity6months

neurophysiological assessment of sural nerve

Vibration perception threshold6 months

Vibration perception threshold was measured with biothesiometer

Trial Locations

Locations (1)

University General Hospital of Thessaloniki AHEPA

🇬🇷

Thessaloniki, Greece

University General Hospital of Thessaloniki AHEPA
🇬🇷Thessaloniki, Greece
© Copyright 2025. All Rights Reserved by MedPath